9 clinical trials found.
-
Risk factors for sudden unexplained death in epilepsy (SUDEP)
The registry is a database created to document SUDEP (sudden unexplained death in epilepsy patients) cases. Our goals are to increase knowledge and awareness about ...Phase
TRIAL ROLE: Sub Investigator
-
Multicenter Study of Epilepsy Surgery Long Term Outcomes Mortality
The Multicenter Study of Epilepsy Surgery – Long Term Outcomes Mortality study aims to examine the various aspects of epilepsy surgery outcomes after more than 10 ...Phase N/A TRIAL ROLE: Sub Investigator
-
Mechanisms and Enhancement of Learning During Sleep
Memory dysfunction represents one of the most common cognitive complaints in patients with epilepsy and significantly impairs quality of life. Our work aims to (1 ...Phase
TRIAL ROLE: Sub Investigator
-
Site for Studies of Patients with Implanted Intracranial Electrodes
Site for The overall goals of this research protocol are 1) to better understand the function of cortical sites that are measured with scalp electrodes ...Phase N/A TRIAL ROLE: Sub Investigator
-
A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER OUTPATIENT PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF STACCATO ALPRAZOLAM IN PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH EPILEPSY WITH A PREDICTABLE SEIZURE PATTERN.
Staccato alprazolam is being developed for the indication of rapid cessation of a prolonged focal or generalized seizure that has not progressed to status epilepticus ...Phase
TRIAL ROLE: Sub Investigator
-
Randomized Double-blind Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Safety Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in ...Phase
TRIAL ROLE: Sub Investigator
-
A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER BASKET STUDY TO EVALUATE THE EFFICACY SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF SATRALIZUMAB IN PATIENTS WITH ANTI-N-METHYL-D-ASPARTIC ACID RECEPTOR (NMDAR) OR ANTI-LEUCINE-RICH GLIOMA-INACTIVATED 1 (LGI1) ENCEPHALITIS
The purpose of this study is to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in participants with anti-N-methyl-D-aspartic acid receptor (NMDAR) and anti-leucine-rich ...Phase
TRIAL ROLE: Sub Investigator
-
A Phase 2/3 Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Epilepsy
The main purpose of this study is to understand whether BHV-7000 can help reduce the number of seizures in subjects with difficult to control or ...Phase
TRIAL ROLE: Sub Investigator
-
SINGLE-CENTER OBSERVATIONAL STUDY OF SEIZURE TYPES IN RARE GENETIC EPILEPSIES
The purpose of this research study is to better describe specific movements that are seizures in rare genetic epilepsies (which may be different than other ...Phase N/A TRIAL ROLE: Sub Investigator
